Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3358 results

Sort By:

DOTATATE PET for Meningioma Radiation Planning

Study ID: NCT06937268
Start Date: 2025-06
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

DOTATATE-PET scan

Sponsor

British Columbia Cancer Agency

Source: clinicaltrials.gov

Share:
Add to list

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Study ID: NCT06669572
Start Date: 2026-01-13
End Date: 2029-03-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Pembrolizumab

Lenvew

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

Study ID: NCT05093972
Start Date: 2026-04-07
End Date: 2026-09-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

22

Intervention / Treatment

Ulonivirine

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery

Study ID: NCT06815289
Start Date: 2025-05-05
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

11

Intervention / Treatment

MR-informed stereotactic radiotherapy

Sponsor

University of Zurich

Source: clinicaltrials.gov

Share:
Add to list

Field-test and Psychometric Validation of the Pectus Excavatum Evaluation Questionnaire in the Dutch Pectus Excavatum Population

Study ID: NCT06918392
Start Date: 2025-09-01
End Date: 2026-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

66

Intervention / Treatment
Sponsor

Zuyderland Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Three Pulp Vitality Tests

Study ID: NCT02636504
Start Date: 2025-06
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Laser Doppler Flowmetry

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma

Study ID: NCT06934044
Start Date: 2025-05-09
End Date: 2028-05-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

Cevoamab

Tocilizumab

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

Developing and Testing a Trauma-Informed Exercise Intervention for Women Veterans With Histories of Sexual Violence

Study ID: NCT06746740
Start Date: 2025-10-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Exercise

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Effects of Health Belief Model Interventions on Preventive Beliefs in Secondhand Smoke Exposure

Study ID: NCT06683144
Start Date: 2025-06-01
End Date: 2025-12-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

93

Intervention / Treatment

Exposure feedback

Interactive education

Social media post

Sponsor

Akdeniz University

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Report-Back Strategies for Long-term and Short-term Exposure Information in Rural Tribal Populations

Study ID: NCT06593340
Start Date: 2026-10
End Date: 2028-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

112

Intervention / Treatment

Messenger 1

Messenger 2

Format 1

Format 2

Sponsor

University of Utah

Source: clinicaltrials.gov

Share:
Add to list